YES Bank has completed the allotment of 3,45,283 equity shares on January 23, 2026, following the exercise of stock options under its employee compensation schemes. The Nomination & Remuneration Committee of the bank approved this allotment, which was executed under the YBL ESOS 2020 Scheme and YBL RSU Plan 2024.

Share Allotment Details

The allotment involved 3,45,283 equity shares with a face value of Rs. 2 each. These shares were issued pursuant to the exercise of stock options under the YBL PESOP 2020 Plan, which operates under the broader YBL ESOS 2020 Scheme, and the YBL RSU Plan 2024.

Impact on Share Capital

The allotment has resulted in an increase in the bank's paid-up share capital. The capital structure transformation reflects the bank's ongoing employee stock option programs.

Employee Stock Option Schemes

The shares were allotted under two key employee compensation plans:

• YBL ESOS 2020 Scheme: This encompasses the YBL PESOP 2020 Plan under which the stock options were exercised
• YBL RSU Plan 2024: The bank's Restricted Stock Unit plan launched in 2024

The bank realized Rs. 42,18,384 from the exercise of these stock options, demonstrating employee confidence in the institution's prospects.

Regulatory Compliance

YES Bank has fulfilled its disclosure obligations by informing both BSE Limited and the National Stock Exchange of India Limited about this corporate action. The bank has also hosted the relevant information on its website at www.yes.bank.in , in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

YES Bank has secured regulatory approval to extend the tenure of Dr. Rajan Pental as Executive Director for an additional six months, reinforcing continuity in its senior leadership team. The Reserve Bank of India (RBI) granted approval on January 21, 2026, for the re-appointment covering the period from February 2, 2026 to July 31, 2026.

RBI Approval and Regulatory Compliance

The bank had submitted an application to the RBI under Regulation 35B of The Banking Regulation Act, 1949, seeking an extension of Dr. Pental's tenure until his superannuation date. The six-month extension bridges the gap until July 31, 2026, when Dr. Pental reaches retirement age.

The re-appointment remains subject to approval from the bank's shareholders, as mandated by corporate governance requirements. YES Bank has confirmed that Dr. Pental is not debarred from holding directorial positions by SEBI or any other regulatory authority.

Leadership Profile and Experience

Dr. Rajan Pental brings extensive experience spanning three decades in the financial services sector. He joined YES Bank in November 2015 and currently oversees a comprehensive portfolio of business verticals. His responsibilities encompass retail banking operations, affluent banking services, NRI banking, private banking, SME banking, rural and agriculture banking, and digital payment solutions.

Key Business Areas Under Leadership

• Branch Banking and Retail Operations
• Credit Cards and Merchant Acquisition
• Third Party Distribution Networks
• Banking Operations and Technology Solutions
• Corporate Social Responsibility initiatives
• Customer Experience and Service Excellence

Professional Background

Prior to joining YES Bank, Dr. Pental held significant positions at HDFC Bank from June 2001 to October 2015, spanning 14 years of progressive responsibilities. In his final role at HDFC Bank, he served as Business Head for Secured Loans and Rural Sales, covering both retail and wholesale vehicle loans. He played an instrumental role in establishing and institutionalizing the Retail Assets Business for HDFC Bank's Northern region operations.

Dr. Pental has also gained experience across various financial institutions including Tata Finance, Esanda Finance & Leasing Ltd (ANZ Grindlays Bank Ltd), Escorts Limited, and Industrial Chemicals Ltd. His expertise spans strategy development, process optimization, and digital innovation in banking services.

Corporate Governance Compliance

YES Bank has fulfilled all disclosure requirements under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The bank has confirmed that no relationships exist between Dr. Pental and other directors that would impact governance standards. The appointment details have been made available on the bank's official website in compliance with listing regulations.